COVID-19 Supplemental work: POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER).

NIH RePORTER · NIH · N01 · $1,499,993 · view on reporter.nih.gov ↗

Abstract

The company proposes to develop a rapid clinical test using miRNA signatures to stratify patients diagnosed with COVID-19 by predicting likelihood of: 1) contracting ARDS related to COVID-19; 2) recovering from ARDS; or 3) mortality. The company has identified a panel of miRNAs from 240 normal and 22 ARDS patients, which was able to accurately (>98%) predict outcomes.

Key facts

NIH application ID: 10259999
Project number: 272201700012C-P00014-9999-2
Recipient: CHROMOLOGIC, LLC
Principal Investigator: NARESH MENON
Activity code: N01
Funding institute: NIH
Fiscal year: 2020
Award amount: $1,499,993
Award type: —
Project period: 2017-03-01 → 2021-05-10